MedTrace Logo

Sodium, Nocturnal Blood Pressure and Nocturnal Pauses in Breathing

NCT06022133 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2023-09-01

No results posted yet for this study

Summary

A reduction of dietary sodium intake reduces blood pressure and risk of cardiovascular disease.

Conditions

  • Sodium Imbalance
  • Nocturnal Blood Pressure
  • Obstructive Sleep Apnea of Adult

Interventions

BEHAVIORAL

Dietary sodium restriction

Selfemployed dietary sodium restriction

Sponsors & Collaborators

  • Jesper Norgaard Bech

    lead OTHER

Principal Investigators

  • Bodil Hornstrup · M.D., Ph.D.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-03
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06022133 on ClinicalTrials.gov